Topics

Odylia Therapeutics Names Ashley Winslow Its Chief Scientific Officer

19:47 EST 7 Nov 2019 | Xconomy

Ashley Winslow is joining Atlanta, GA-based Odylia Therapeutics, a nonprofit organization that aims to accelerate the development of gene therapies for people with inherited retinal disease, as its chief scientific officer. Most recently she was the senior director of portfolio development and translational research at the Orphan Disease Center at the University of Pennsylvania; she […]

Original Article: Odylia Therapeutics Names Ashley Winslow Its Chief Scientific Officer

NEXT ARTICLE

More From BioPortfolio on "Odylia Therapeutics Names Ashley Winslow Its Chief Scientific Officer"

Quick Search

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...